Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

Clinical trial NCT05377905 · RECRUITING

Trial details

NCT number: NCT05377905
Sponsor: Falo, Louis, MD
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cutaneous Squamous Cell Carcinoma Skin Cancers - Squamous Cell Carcinoma

Start date: 2023-09-13
Primary completion: 2027-03-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.